Skip to main content
PEGASUS MERCANTILE INC. logo

PEGASUS MERCANTILE INC. — Investor Relations & Filings

Ticker · LOAN ISIN · CA70557Y2042 LEI · 529900BGK3BYC4VSF690 CSE Financial and insurance activities
Filings indexed 424 across all filing types
Latest filing 2023-02-06 Regulatory Filings
Country CA Canada
Listing CSE LOAN

About PEGASUS MERCANTILE INC.

https://xtacytherapeutics.com/

Pegasus Mercantile Inc. is a diversified venture capital firm and prospect generator that provides financial, operational, and management assistance to high-growth companies. The firm specializes as an incubator for early-stage investments within the wellness consumer goods market, focusing on biotechnology, hemp, CBD, functional mushrooms, and psychedelics. Its investment strategy targets solutions for chronic pain, depression, and mental illness, often utilizing pioneering techniques such as micro-dosing organic and synthetic compounds. Pegasus Mercantile assists portfolio companies from startup through commercialization, specializing in navigating complex regulatory requirements, including clinical trials, patenting, and legislative approvals. The firm also provides debt financing facilities.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2023-02-06 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a news release announcing that Global Wellness Strategies Inc. has missed its filing deadline for its audited annual financial statements and related management discussion and analysis for the fiscal year ended September 30, 2022. It states that the company has been granted a Management Cease Trade Order (MCTO) due to the delay caused by a change in audit firms. The document does not contain the actual annual report or financial statements but rather discusses the delay and regulatory consequences. It is an announcement about the status of regulatory filings and compliance, not the filings themselves. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such announcements and compliance-related disclosures.
2023-02-02 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing an update on clinical trials related to MDMA by Global Wellness Strategies. It contains no financial statements, no regulatory form references, no voting results, no management or board changes, no earnings data, and no detailed financial or operational report. The text is a corporate announcement about business activities and partnerships, with forward-looking statements but no substantive financial or regulatory filing content. The document length is 4597 characters, which is relatively short and consistent with a news or update release rather than a formal report. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is best classified as a Regulatory Filing (RNS) as a general announcement that does not fit other specific categories.
2023-01-31 English
News release - English.pdf
Regulatory Filings
2022-12-06 English
News release - English.pdf
Regulatory Filings
2022-11-17 English
News release - English.pdf
Regulatory Filings
2022-11-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.